Last reviewed · How we verify
NCT07302191: HICONEXOBWO
High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women
NA trial testing High-Intensity Interval in Women Veterans in 58 participants. Completed in 8 December 2025.
20 November 2025
Quick facts
| Lead sponsor | University of Valladolid |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 58 |
| Start date | 2 September 2025 |
| Primary completion | 20 November 2025 |
| Estimated completion | 8 December 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- High-Intensity Interval
- concurrent training
- Control Group — full drug profile →
Conditions studied
- Women Veterans — all drugs for Women Veterans →
- Obese Women — all drugs for Obese Women →
- Postmenopausal — all drugs for Postmenopausal →
- Sedentary Lifestlye — all drugs for Sedentary Lifestlye →
Sponsor
University of Valladolid
Who can join
Adults 50 to 65, female only, with Women Veterans or Obese Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Menopause is associated with body composition change, an increase in the cardio-metabolic risk factor for oxidative stress. Nevertheless, it has been suggested that regular physical training is an effective non-pharmacological intervention to reduce oxidative stress and cardio-metabolic disorders in menopausal individuals. Therefore, the present study was conducted to compare the effects of twelve weeks of high-intensity interval training (HIIT) and concurrent (Conc) and on body composition, cardio-metabolic indices and oxidative stress in sedentary obese postmenopausal women. Materials and methods: Forty-five menopausal obese women voluntarily participated and were randomly assigned into three groups: a) HIIT (6-12×60s of high intensity training (85-95% HRMax) and then running for 60 seconds with low intensity (55-60% HRMax)), b) concurrent endurance (performed on training with 55-75% HRMax) and strength training (including two sets in eight exercise stations with 55-75% 1RM)) and c) control group. Training programs were done for twelve weeks, 3 times per week. Body composition, cardio-metabolic indices and oxidative stress markers were measured before and after twelve weeks of exercise training program.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07302191
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Women Veterans
Currently open trials in the same condition.
- NCT05683132 — Treatments in Women Veterans With Insomnia and PTSD · NA · recruiting
Other University of Valladolid trials
Trials by the same sponsor.
- NCT07307391 — Exercise in Extreme Hot Weather Conditions · NA · completed
- NCT06696378 — Melatonin Supplementation and Exercise Program in Breast Cancer Women · NA · recruiting
- NCT06616181 — TDCS and Tele-rehabilitation Exercise in Fibromyalgia · NA · not yet recruiting
- NCT06326229 — Clinical Validation of Musculoskeletal ICF Core Set in Primary Care Physiotherapy · recruiting
- NCT06289439 — Effect of Green Tea Supplementation in Older Adult Women · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07302191 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Valladolid
- Last refreshed: 31 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07302191.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing